the podcast on
Semaglutide drug Wegovy has been available in New Zealand for a couple of months now, and more Kiwis are learning about the effects.
The drug has transformed our ability to manage obesity and type 2 diabetes, and has shown potential for a wide range of conditions such as Alzheimer鈥檚, addiction and depression.
General Practice NZ chair Dr Bryan Betty joined the Afternoons team to discuss further - and highlight some potential drawbacks.
LISTEN ABOVE
Take your Radio, Podcasts and Music with you
Get the iHeart App
Get more of the radio, music and podcasts you love with the FREE iHeartRadio app. Scan the QR code to download now.
Download from the app stores
Stream unlimited music, thousands of radio stations and podcasts all in one app. iHeartRadio is easy to use and all FREE
